Taken together, our data prove that UBC9-mediated STAT4 SUMOylation plays a vital role in TAM-associated immunosuppression and provide an important prospect for the development of immunotherapies for PCa treatment. The gene discussed is UBE2I; the disease is posterior cortical atrophy.